All Pharma News
FDA Issues Complete Response Letter for Satsuma’s STS101

FDA Issues Complete Response Letter for Satsuma’s STS101
PRESS RELEASE
19 Jan 2024
Share Share
Satsuma Pharma and SNBL Announce Three Abstracts on STS101

Satsuma Pharma and SNBL Announce Three Abstracts on STS101
GLOBENEWSWIRE
15 Jun 2023
Share Share
Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101

Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101
GLOBENEWSWIRE
18 May 2023
Share Share
SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General Louisiana

SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General Louisiana
BUSINESSWIRE
21 Apr 2023
Share Share
Satsuma Announces 3Abstracts Accepted at The 75th American Academy Neurology

Satsuma Announces 3Abstracts Accepted at The 75th American Academy Neurology
GLOBENEWSWIRE
21 Apr 2023
Share Share
With skin in the game, Satsuma`s partner offers buyout

With skin in the game, Satsuma`s partner offers buyout
James Waldron FIERCE BIOTECH
17 Apr 2023
Share Share
Satsuma peels off staff, cutting head count by 36% to save cash

Satsuma peels off staff, cutting head count by 36% to save cash
Nick Paul Taylor FIERCE BIOTECH
29 Mar 2023
Share Share
Satsuma Reports Fourth Quarter and Full Year 2022 Financial Results

Satsuma Reports Fourth Quarter and Full Year 2022 Financial Results
GLOBENEWSWIRE
28 Mar 2023
Share Share
Satsuma to Participate in the Virtual SVB Securities Global Biopharma Conference

Satsuma to Participate in the Virtual SVB Securities Global Biopharma Conference
GLOBENEWSWIRE
02 Feb 2023
Share Share
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update

Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
GLOBENEWSWIRE
20 Dec 2022
Share Share